Upstream Bio Stock Technical Analysis
| UPB Stock | 30.94 0.51 1.68% |
As of the 29th of January, Upstream Bio has the Risk Adjusted Performance of 0.1126, coefficient of variation of 696.0, and Semi Deviation of 3.4. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Upstream Bio, as well as the relationship between them.
Upstream Bio Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Upstream, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to UpstreamUpstream Bio's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Upstream Bio Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 49.75 | Strong Buy | 4 | Odds |
Most Upstream analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Upstream stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Upstream Bio, talking to its executives and customers, or listening to Upstream conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Upstream Bio. If investors know Upstream will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Upstream Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (6.40) | Revenue Per Share | Quarterly Revenue Growth 0.125 | Return On Assets | Return On Equity |
The market value of Upstream Bio is measured differently than its book value, which is the value of Upstream that is recorded on the company's balance sheet. Investors also form their own opinion of Upstream Bio's value that differs from its market value or its book value, called intrinsic value, which is Upstream Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Upstream Bio's market value can be influenced by many factors that don't directly affect Upstream Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Upstream Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Upstream Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Upstream Bio's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Upstream Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Upstream Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Upstream Bio.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Upstream Bio on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Upstream Bio or generate 0.0% return on investment in Upstream Bio over 90 days. Upstream Bio is related to or competes with Merck, SEI Investments, Demant AS, Coca Cola, Golub Capital, First Trust, and Oric Pharmaceuticals. Upstream Bio is entity of United States. It is traded as Stock on NASDAQ exchange. More
Upstream Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Upstream Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Upstream Bio upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.02 | |||
| Information Ratio | 0.1294 | |||
| Maximum Drawdown | 24.37 | |||
| Value At Risk | (5.24) | |||
| Potential Upside | 7.87 |
Upstream Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Upstream Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Upstream Bio's standard deviation. In reality, there are many statistical measures that can use Upstream Bio historical prices to predict the future Upstream Bio's volatility.| Risk Adjusted Performance | 0.1126 | |||
| Jensen Alpha | 0.606 | |||
| Total Risk Alpha | 0.3046 | |||
| Sortino Ratio | 0.1388 | |||
| Treynor Ratio | 10.5 |
Upstream Bio January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1126 | |||
| Market Risk Adjusted Performance | 10.51 | |||
| Mean Deviation | 3.3 | |||
| Semi Deviation | 3.4 | |||
| Downside Deviation | 4.02 | |||
| Coefficient Of Variation | 696.0 | |||
| Standard Deviation | 4.31 | |||
| Variance | 18.56 | |||
| Information Ratio | 0.1294 | |||
| Jensen Alpha | 0.606 | |||
| Total Risk Alpha | 0.3046 | |||
| Sortino Ratio | 0.1388 | |||
| Treynor Ratio | 10.5 | |||
| Maximum Drawdown | 24.37 | |||
| Value At Risk | (5.24) | |||
| Potential Upside | 7.87 | |||
| Downside Variance | 16.13 | |||
| Semi Variance | 11.59 | |||
| Expected Short fall | (3.65) | |||
| Skewness | (0.06) | |||
| Kurtosis | 0.934 |
Upstream Bio Backtested Returns
Upstream Bio appears to be not too volatile, given 3 months investment horizon. Upstream Bio owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0904, which indicates the firm had a 0.0904 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Upstream Bio, which you can use to evaluate the volatility of the company. Please review Upstream Bio's Semi Deviation of 3.4, risk adjusted performance of 0.1126, and Coefficient Of Variation of 696.0 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Upstream Bio holds a performance score of 7. The entity has a beta of 0.058, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Upstream Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Upstream Bio is expected to be smaller as well. Please check Upstream Bio's skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether Upstream Bio's existing price patterns will revert.
Auto-correlation | 0.52 |
Modest predictability
Upstream Bio has modest predictability. Overlapping area represents the amount of predictability between Upstream Bio time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Upstream Bio price movement. The serial correlation of 0.52 indicates that about 52.0% of current Upstream Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.52 | |
| Spearman Rank Test | 0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 3.42 |
Upstream Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Upstream Bio Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Upstream Bio volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Upstream Bio Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Upstream Bio on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Upstream Bio based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Upstream Bio price pattern first instead of the macroeconomic environment surrounding Upstream Bio. By analyzing Upstream Bio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Upstream Bio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Upstream Bio specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Current Ratio | 17.96 | 44.63 | 40.16 | 42.17 | Net Debt To EBITDA | 0.64 | 4.17 | 3.75 | 3.94 |
Upstream Bio January 29, 2026 Technical Indicators
Most technical analysis of Upstream help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Upstream from various momentum indicators to cycle indicators. When you analyze Upstream charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1126 | |||
| Market Risk Adjusted Performance | 10.51 | |||
| Mean Deviation | 3.3 | |||
| Semi Deviation | 3.4 | |||
| Downside Deviation | 4.02 | |||
| Coefficient Of Variation | 696.0 | |||
| Standard Deviation | 4.31 | |||
| Variance | 18.56 | |||
| Information Ratio | 0.1294 | |||
| Jensen Alpha | 0.606 | |||
| Total Risk Alpha | 0.3046 | |||
| Sortino Ratio | 0.1388 | |||
| Treynor Ratio | 10.5 | |||
| Maximum Drawdown | 24.37 | |||
| Value At Risk | (5.24) | |||
| Potential Upside | 7.87 | |||
| Downside Variance | 16.13 | |||
| Semi Variance | 11.59 | |||
| Expected Short fall | (3.65) | |||
| Skewness | (0.06) | |||
| Kurtosis | 0.934 |
Upstream Bio January 29, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Upstream stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 19,592 | ||
| Daily Balance Of Power | 0.38 | ||
| Rate Of Daily Change | 1.02 | ||
| Day Median Price | 30.43 | ||
| Day Typical Price | 30.60 | ||
| Price Action Indicator | 0.77 |
Complementary Tools for Upstream Stock analysis
When running Upstream Bio's price analysis, check to measure Upstream Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Upstream Bio is operating at the current time. Most of Upstream Bio's value examination focuses on studying past and present price action to predict the probability of Upstream Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Upstream Bio's price. Additionally, you may evaluate how the addition of Upstream Bio to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |